A look at the revised prospectus indicates that I'm wrong about other partners income, the 36 month window is applied to Novartis alone. While this is probably where the money would come from, XON could certainly benefit from other income from other GNVC partners.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.